Fluorine‐Substituted Rhenium(I) Metallocycle: A New Class of Potent Anticancer Agent
Chemistry – An Asian Journal · 2025
DOI: 10.1002/asia.202401656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Reema L Borkar und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Hyderabad, Hyderabad, 500 046, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Rhenium, Fluorine, Coordination Complexes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: IIT-Hyderabad, SERB, Science and Engineering Research Board.
Abstract (Originalsprache)
Fluorine and nonfluorine substituted rhenium(I) metallocycles, fac ‐[{Re(CO) 3 } 2 ( μ ‐SO 4 )(L1) 2 ] ( C1 ) and fac ‐[{Re(CO) 3 } 2 ( μ ‐SO 4 )(L2) 2 ] ( C2 ), respectively, were synthesized using Re 2 (CO) 10 , sodium bisulfite, fluorobenzimidazolyl/benzimidazolyl‐based ditopic nitrogen‐donor ligands (L1/L2), and toluene–acetone via coordination‐driven one‐pot solvothermal approach. The metallocycles were characterized using elemental analysis, ESI‐TOF‐MS, ATR‐IR, NMR, and PXRD methods. The molecular structures of C1 ·9(DMSO), C1 ·(toluene)(acetone), and C2 ·(toluene) were determined using SCXRD analysis. The in vitro cytotoxicity study of C1 and C2 was performed against cervical (HeLa) and skin (B16) cancer cells. Murine fibroblast (L929) and mouse myoblast (C2C12) cells were used as noncarcinogenic model cell lines for biocompatibility determination. The metallocycles exhibited potent anticancer activity against both cancer cell lines, showing greater efficacy than the commonly used cisplatin. Moreover, fluorine‐substituted C1 metallocycle exhibited significantly higher anticancer activity than nonfluorinated C2 metallocycle, indicating a fluorine effect. Further, in‐depth studies of C1 on HeLa cells showed elevated intracellular ROS generation, disruption of mitochondrial membrane potential, and antiproliferative properties. The in vitro studies also revealed its ability to bind with DNA and induce changes in cellular morphology, thus leading to DNA damage and cancer cell death by apoptosis. Molecular docking studies of the metallocycles with B‐DNA macromolecule revealed the binding sites, binding affinity, and type of noncovalent interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of Hyderabad, Hyderabad, 500 046, India.
- Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, 502 284, India.
- Department of Chemistry, Thiagarajar College of Engineering, Madurai, 625 015, India.
ORCID-Profile: Reema L Borkar
Förderung
- IIT-Hyderabad
- SERB
- Science and Engineering Research Board
Zitieren
APA
Borkar, R. L., Putta, C. L., Shankar, B., Bhattacharjee, B., Rengan, A. K., & Sathiyendiran, M. (2025). Fluorine‐Substituted Rhenium(I) Metallocycle: A New Class of Potent Anticancer Agent. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202401656
Vancouver
Borkar RL, Putta CL, Shankar B, Bhattacharjee B, Rengan AK, Sathiyendiran M. Fluorine‐Substituted Rhenium(I) Metallocycle: A New Class of Potent Anticancer Agent. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202401656
BibTeX
@article{Borkar2025,
author = {Borkar, Reema L and Putta, Chandra Lekha and Shankar, Bhaskaran and Bhattacharjee, Basu and Rengan, Aravind Kumar and Sathiyendiran, Malaichamy},
title = {Fluorine‐Substituted Rhenium(I) Metallocycle: A New Class of Potent Anticancer Agent},
journal = {Chemistry – An Asian Journal},
year = {2025},
doi = {10.1002/asia.202401656}
}
EUVIMED